Compliance With Neoadjuvant Chemotherapy in T4 Oral Cancers: Place, Person, Socioeconomic Status, or Assistance

PURPOSE: Approximately 15% to 20% of our patients with head and neck cancer receiving neoadjuvant chemotherapy (NACT) discontinue therapy because of various nonmedical reasons. We sought to analyze the factors associated with treatment default and noncompliance among these patients. PATIENTS AND MET...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Glob Oncol
Asıl Yazarlar: Patil, Vijay M., Noronha, Vanita, Joshi, Amit, Muddu, Vamshi, Dhumal, Sachin, Bhattacharjee, Atanu, Prabhash, Kumar
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2015
Konular:
ORIGINAL REPORTS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5539870/
https://ncbi.nlm.nih.gov/pubmed/28804775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JGO.2015.000265
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller